aTyr Pharma Announces First Quarter 2022 Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- GlobalFoundries and Marvell expand SiGe capacity for optical networking
aTyr Pharma (LIFE) Misses Q1 EPS by 11c
May 9, 2022 5:17 PM EDTaTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.44), $0.11 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
... More